Advisor Partners LLC boosted its stake in Mylan N.V. (NASDAQ:MYL) by 20.8% during the second quarter, Holdings Channel reports. The institutional investor owned 6,452 shares of the company’s stock after buying an additional 1,112 shares during the period. Advisor Partners LLC’s holdings in Mylan N.V. were worth $250,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Raymond James Trust N.A. boosted its stake in Mylan N.V. by 33.8% in the first quarter. Raymond James Trust N.A. now owns 10,215 shares of the company’s stock valued at $398,000 after buying an additional 2,583 shares during the period. Legacy Private Trust Co. acquired a new position in shares of Mylan N.V. during the first quarter worth about $202,000. Bank of Montreal Can boosted its position in shares of Mylan N.V. by 70.1% in the first quarter. Bank of Montreal Can now owns 1,050,878 shares of the company’s stock worth $40,974,000 after buying an additional 433,171 shares during the last quarter. Capstone Asset Management Co. boosted its position in shares of Mylan N.V. by 1.5% in the first quarter. Capstone Asset Management Co. now owns 18,186 shares of the company’s stock worth $709,000 after buying an additional 260 shares during the last quarter. Finally, National Investment Services Inc. WI boosted its position in shares of Mylan N.V. by 15.8% in the first quarter. National Investment Services Inc. WI now owns 36,366 shares of the company’s stock worth $1,418,000 after buying an additional 4,969 shares during the last quarter. 70.19% of the stock is currently owned by hedge funds and other institutional investors.

Mylan N.V. (MYL) opened at 30.88 on Friday. The company has a market cap of $16.52 billion, a P/E ratio of 24.96 and a beta of 1.27. Mylan N.V. has a 12 month low of $29.58 and a 12 month high of $49.42. The stock has a 50 day moving average of $37.34 and a 200-day moving average of $39.01.

Mylan N.V. (NASDAQ:MYL) last announced its earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. The firm had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The business’s revenue for the quarter was up 15.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.16 EPS. Equities research analysts expect that Mylan N.V. will post $4.68 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Mylan N.V. (NASDAQ:MYL) Shares Bought by Advisor Partners LLC” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/12/mylan-n-v-nasdaqmyl-shares-bought-by-advisor-partners-llc.html.

A number of brokerages have issued reports on MYL. Zacks Investment Research raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. Cowen and Company reaffirmed a “market perform” rating and issued a $43.00 price objective (down from $55.00) on shares of Mylan N.V. in a research note on Sunday, May 21st. UBS AG reaffirmed a “buy” rating and issued a $46.00 price objective (down from $50.00) on shares of Mylan N.V. in a research note on Thursday. BidaskClub cut shares of Mylan N.V. from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $33.00 price objective (down from $41.00) on shares of Mylan N.V. in a research note on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $47.83.

In other news, President Rajiv Malik sold 25,000 shares of the stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now owns 799,855 shares in the company, valued at $31,994,200. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Anthony Mauro sold 10,000 shares of the stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the sale, the insider now owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company’s stock.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.